Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure
Condition: Acute-On-Chronic Liver Failure Interventions: Drug: 3 times hUC-MSC and 2 times placebo; Drug: 3 times hUC-MSC and 2 times hUC-MSC; Drug: Placebo Sponsors: Beijing 302 Hospital; Shulan (Hang Zhou) Hospital; BeijingYouan Hospital; Shenzhen Third People's Hospital; Shen Zhen Wingor Biotechnology CO. LTD Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Hospitals | Liver | Liver Transplant | Research | Stem Cell Therapy | Stem Cells | Transplants | Urology & Nephrology